Virtual multidisciplinary care for heart failure patients with cardiac resynchronization therapy devices during the Coronavirus Disease 2019 pandemic
Megan Zhao(Johns Hopkins University), Saumya Das(Harvard University), Mary Orencole(Harvard University), Jagmeet P. Singh(Massachusetts General Hospital), Dingxin Qin(Harvard University), William J. Hucker(Massachusetts General Hospital), E. Kevin Heist(Massachusetts General Hospital), Nasrien E. Ibrahim, Nupur Dandwate(Harvard University), Giulio Cataldo(Harvard University), Krishan Sharma(Harvard University), Christopher Newton‐Cheh(Massachusetts General Hospital)
Cited by 12
Related Papers
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
|Hypertension|2018|1.1k
Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk
|Nature Genetics|2017|589
Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction
|Nature Genetics|2010|358
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America
|Journal of Cardiac Failure|2024|357